Internal Medicine, Gastroenterology · Houston, TX
NPI
1952372484
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
4
Hospital affiliations
11307 Fm 1960 Rd. West, Suite 370
Houston, TX, 77065
Phone (281) 970-6027
Medicare paid, 2024
$82K
797 services
Medicare patients, 2024
388
Average age 72
Drug cost, 2024
$481K
2,520 prescriptions
Company payments, 2025
$1,383
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arturo A Bravo was code 99214 (office e&m - established), 184 times for 165 patients. In total Arturo A Bravo billed 797 services in 28 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 184 | 165 | $83.86 | $15K |
| 43239 Upper GI Endoscopy | Facility | 125 | 118 | $68.08 | $8,510 |
| 45380 Lower GI Endoscopy - Other | Facility | 95 | 95 | $130.90 | $12K |
| 99213 Office E&M - Established | Office | 94 | 82 | $60.60 | $5,697 |
| 45385 Colonoscopy - Lesion Removal | Facility | 77 | 72 | $173.26 | $13K |
| 99204 Office E&M - New | Office | 52 | 52 | $109.05 | $5,670 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 34 | 34 | $164.43 | $5,590 |
| 99203 Office E&M - New | Office | 30 | 30 | $66.56 | $1,997 |
| 45378 Lower GI Endoscopy - Other | Facility | 29 | 27 | $127.64 | $3,701 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 26 | 26 | $164.52 | $4,278 |
By year: 2022 $104K for 969 services; 2023 $85K for 811 services; 2024 $82K for 797 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arturo A Bravo prescribed most often to Medicare patients was Pantoprazole Sodium, with 716 prescriptions and refills. In total Arturo A Bravo wrote 2,520 Medicare prescriptions that cost $481K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 716 | 1,981 | 293 | $8,324 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 336 | 336 | 319 | $55K |
| Dicyclomine Hcl Generic | 277 | 286 | 119 | $1,920 |
| Omeprazole Generic | 271 | 663 | 125 | $4,080 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 184 | 195 | 177 | $11K |
| Linzess Linaclotide | 124 | 292 | 57 | $151K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 65 | 65 | 61 | $909 |
| Famotidine Generic | 43 | 127 | 20 | $751 |
| Esomeprazole Magnesium Generic | 38 | 114 | 15 | $1,673 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 37 | 37 | 33 | $6,390 |
| Lactulose Generic | 30 | 42 | Under 11 | $870 |
| Dexlansoprazole Dr Dexlansoprazole | 28 | 76 | Under 11 | $12K |
| Xifaxan Rifaximin | 27 | 27 | 23 | $65K |
| Metronidazole Generic | 27 | 27 | 26 | $189 |
| Budesonide Dr Budesonide | 25 | 35 | Under 11 | $2,360 |
Brand drugs: 664 claims; generic drugs: 1,856 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arturo A Bravo $1,383 ($1,383 in general payments such as food, travel and fees) from 11 companies. The largest payer was Medtronic, Inc. with $583.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 14 | $583 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 5 | $209 |
| Abbvie Inc. ABBV | 11 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 11 | $143 |
| Braintree Laboratories, Inc. | 4 | $83.77 |
| Ardelyx, Inc. ARDX | 3 | $58.22 |
| Janssen Biotech, Inc. JNJ | 2 | $44.04 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $25.56 |
| Azurity Pharmaceuticals, Inc. | 1 | $18.09 |
| CapsoVision, Inc. CV | 1 | $17.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.